| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |